Extended antimicrobial treatment of bacterial vaginosis combined with human lactobacilli to find the best treatment and minimize the risk of relapses

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Larsson, Per Göran ^a   Brandsborg, Erik ^b   Forsum, Urban ^c   Pendharkar, Sonal ^d   Andersen, Kasper K ^d   Nasic, Salmir ^e   Hammarström, Lennart ^d   Marcotte, Harold ^d  

^a UNIVERSITY OF SKÖVDE   (Sweden)

^b Bifodan AS   (Denmark)

^c LINKÖPING UNIVERSITY   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e SKARABORG HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; ECOVAG; LACIBIOS; METRONIDAZOLE; PROBIOTIC AGENT; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT;

ADULT; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CLINICAL PRACTICE; CLINICAL STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GEL; HUMAN; INFECTION RISK; LACTOBACILLUS; LACTOBACILLUS CRISPATUS; LACTOBACILLUS GASSERI; LACTOBACILLUS JENSENEI; LACTOBACILLUS RHAMNOSUS; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; RELAPSE; SEXUALITY; TREATMENT DURATION; VAGINITIS; GROWTH, DEVELOPMENT AND AGING; MIDDLE AGED; RECURRENT DISEASE; TREATMENT OUTCOME;

ADULT; ANTI-INFECTIVE AGENTS; CLINDAMYCIN; FEMALE; HUMANS; LACTOBACILLUS; METRONIDAZOLE; MIDDLE AGED; PROBIOTICS; RECURRENCE; TREATMENT OUTCOME; VAGINOSIS, BACTERIAL;

EID: 80051801267     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-223     Document Type: Article

References (52)

1. Fredricks DN, Fiedler TL, Thomas KK, Oakley BB, Marrazzo JM. Targeted PCR for detection of vaginal bacteria associated with bacterial vaginosis. J Clin Microbiol 2007, 45(10):3270-3276. 10.1128/JCM.01272-07, 2045326, 17687006.
2. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists, Number 72, May 2006: Vaginitis. Obstet Gynecol 2006, 107(5):1195-1206. 10.1097/00006250-200605000-00049, 16648432.
3. Kane KY, Pierce R. What are the most effective treatments for bacterial vaginosis in nonpregnant women?. J Fam Pract 2001, 50(5):399-400.
4. Joesoef MR, Schmid G. Bacterial vaginosis. Clin Evid 2004, (11):2054-2063.
5. Larsson PG, Forsum U. Bacterial vaginosis--a disturbed bacterial flora and treatment enigma. Apmis 2005, 113(5):305-316. 10.1111/j.1600-0463.2005.apm_113501.x, 16011656.
6. Bradshaw CS, Morton AN, Hocking J, Garland SM, Morris MB, Moss LM, Horvath LB, Kuzevska I, Fairley CK. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis 2006, 193(11):1478-1486. 10.1086/503780, 16652274.
7. Sobel JD, Ferris D, Schwebke J, Nyirjesy P, Wiesenfeld HC, Peipert J, Soper D, Ohmit SE, Hillier SL. Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol 2006, 194(5):1283-1289. 10.1016/j.ajog.2005.11.041, 16647911.
8. Forsum U, Hallen A, Larsson PG. Bacterial vaginosis--a laboratory and clinical diagnostics enigma. Apmis 2005, 113(3):153-161. 10.1111/j.1600-0463.2005.apm1130301.x, 15799757.
9. Vasquez A, Jakobsson T, Ahrne S, Forsum U, Molin G. Vaginal lactobacillus flora of healthy Swedish women. J Clin Microbiol 2002, 40(8):2746-2749. 10.1128/JCM.40.8.2746-2749.2002, 120688, 12149323.
10. Zozaya-Hinchliffe M, Lillis R, Martin DH, Ferris MJ. Quantitative PCR assessments of bacterial species in women with and without bacterial vaginosis. J Clin Microbiol 2010, 48(5):1812-1819. 10.1128/JCM.00851-09, 2863870, 20305015.
11. Reid G, Charbonneau D, Erb J, Kochanowski B, Beuerman D, Poehner R, Bruce AW. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol 2003, 35(2):131-134. 10.1016/S0928-8244(02)00465-0, 12628548.
12. Anukam K, Osazuwa E, Ahonkhai I, Ngwu M, Osemene G, Bruce AW, Reid G. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. Microbes Infect 2006, 8(6):1450-1454. 10.1016/j.micinf.2006.01.003, 16697231.
13. Larsson PG, Stray-Pedersen B, Ryttig KR, Larsen S. Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study. BMC Womens Health 2008, 8(1):3. 10.1186/1472-6874-8-3, 18197974.
14. Ventura M, Zink R. Specific identification and molecular typing analysis of Lactobacillus johnsonii by using PCR-based methods and pulsed-field gel electrophoresis. FEMS Microbiol Lett 2002, 217(2):141-154. 10.1111/j.1574-6968.2002.tb11468.x, 12480097.
15. Van Reenen CA, Dicks LM. Evaluation of numerical analysis of random amplified polymorphic DNA (RAPD)-PCR as a method to differentiate Lactobacillus plantarum and Lactobacillus pentosus. Curr Microbiol 1996, 32(4):183-187. 10.1007/s002849900033, 8867459.
16. Torriani S, Zapparoli G, Dellaglio F. Use of PCR-based methods for rapid differentiation of Lactobacillus delbrueckii subsp. bulgaricus and L. delbrueckii subsp. lactis. Appl Environ Microbiol 1999, 65(10):4351-4356. 91577, 10508059.
17. Fitzsimons NA, Cogan TM, Condon S, Beresford T. Phenotypic and genotypic characterization of non-starter lactic acid bacteria in mature cheddar cheese. Appl Environ Microbiol 1999, 65(8):3418-3426. 91514, 10427029.
18. Song JY, Lin LL, Shott S, Kimber N, Tangora J, Cohen A, Wells A, Maezes M, Aroutcheva A, Faro S. Evaluation of the Strep B OIA test compared to standard culture methods for detection of group B streptococci. Infect Dis Obstet Gynecol 1999, 7(4):202-205. 1784740, 10449270.
19. Jorgensen J, Turnidge J. Susceptibility test methods: dilution and disk diffusion methods. Manual of Clinical Microbiology 2003, 1108-1125. Washington, DC.: ASM Press, Murray P, Baron E, Jorgensen J, Pfaller M, Yolken R, 8, Volume.
20. Anukam KC, Osazuwa E, Osemene GI, Ehigiagbe F, Bruce AW, Reid G. Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis. Microbes Infect 2006, 8(12-13):2772-2776. 10.1016/j.micinf.2006.08.008, 17045832.
21. Amsel R, Totten PA, Spiegel CA, Chen K, Eschenbach DA, Holmes KK. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983, 74:14-22. 10.1016/0002-9343(83)91112-9, 6600371.
22. Colli E, Landoni M, Parazzini F. Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Genitourin Med 1997, 73(4):267-270. 1195855, 9389947.
23. Eriksson K, Carlsson B, Forsum U, Larsson PG. A double-blind treatment study of bacterial vaginosis with normal vaginal lactobacilli after an open treatment with vaginal clindamycin ovules. Acta Derm Venereol 2005, 85(1):42-46. 10.1080/00015550410022249, 15848990.
24. Hay PE, Lamont RF, Taylor-Robinson D, Morgan DJ, Ison C, Pearson J. Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage. Bmj 1994, 308(6924):295-298. 2539287, 8124116.
25. Ison CA, Hay PE. Validation of a simplified grading of Gram stained vaginal smears for use in genitourinary medicine clinics. Sex Transm Infect 2002, 78(6):413-415. 10.1136/sti.78.6.413, 1758337, 12473800.
26. Koll P, Mandar R, Smidt I, Hutt P, Truusalu K, Mikelsaar RH, Shchepetova J, Krogh-Andersen K, Marcotte H, Hammarstrom L, et al. Screening and Evaluation of Human Intestinal Lactobacilli for the Development of Novel Gastrointestinal Probiotics. Curr Microbiol 2010,
27. Wilson J. Managing recurrent bacterial vaginosis. Sex Transm Infect 2004, 80(1):8-11. 10.1136/sti.2002.002733, 1758381, 14755028.
28. Boris J, Pahlson C, Larsson PG. Six years observation after successful treatment of bacterial vaginosis. Infect Dis Obstet Gynecol 1997, 5(4):297-302. 2364553, 18476155.
29. Marcone V, Calzolari E, Bertini M. Effectiveness of vaginal administration of Lactobacillus rhamnosus following conventional metronidazole therapy: how to lower the rate of bacterial vaginosis recurrences. New Microbiol 2008, 31(3):429-433.
30. Marcone V, Rocca G, Lichtner M, Calzolari E. Long-term vaginal administration of Lactobacillus rhamnosus as a complementary approach to management of bacterial vaginosis. Int J Gynaecol Obstet 2010, 110(3):223-226. 10.1016/j.ijgo.2010.04.025, 20573348.
31. Vaishnavi C. Established and potential risk factors for Clostridum difficile infection. Indian J Med Microbiol 2009, 27(4):289-300. 10.4103/0255-0857.55436, 19736396.
32. Cook RL, Redondo-Lopez V, Schmitt C, Meriwether C, Sobel JD. Clinical, microbiological, and biochemical factors in recurrent bacterial vaginosis. J Clin Microbiol 1992, 30(4):870-877. 265177, 1572973.
33. Winceslaus SJ, Calver G. Recurrent bacterial vaginosis--an old approach to a new problem. Int J STD AIDS 1996, 7(4):284-287. 10.1258/0956462961917816, 8876361.
34. Hay P. Recurrent Bacterial Vaginosis. Curr Infect Dis Rep 2000, 2(6):506-512. 10.1007/s11908-000-0053-5, 11095900.
35. Hay P. Life in the littoral zone: lactobacilli losing the plot. Sex Transm Infect 2005, 81(2):100-102. 10.1136/sti.2003.007161, 1764678, 15800083.
36. Wilson JD, Shann SM, Brady SK, Mammen-Tobin AG, Evans AL, Lee RA. Recurrent bacterial vaginosis: the use of maintenance acidic vaginal gel following treatment. Int J STD AIDS 2005, 16(11):736-738. 10.1258/095646205774763081, 16303068.
37. Sobel JD. Vulvovaginal candidosis. Lancet 2007, 369(9577):1961-1971. 10.1016/S0140-6736(07)60917-9, 17560449.
38. Ehrstrom S, Daroczy K, Rylander E, Samuelsson C, Johannesson U, Anzen B, Pahlson C. Lactic acid bacteria colonization and clinical outcome after probiotic supplementation in conventionally treated bacterial vaginosis and vulvovaginal candidiasis. Microbes Infect 2010, 12(10):691-699. 10.1016/j.micinf.2010.04.010, 20472091.
39. Falagas ME, Betsi GI, Athanasiou S. Probiotics for the treatment of women with bacterial vaginosis. Clin Microbiol Infect 2007, 13(7):657-664. 10.1111/j.1469-0691.2007.01688.x, 17633390.
40. Antonio MA, Meyn LA, Murray PJ, Busse B, Hillier SL. Vaginal colonization by probiotic Lactobacillus crispatus CTV-05 is decreased by sexual activity and endogenous Lactobacilli. J Infect Dis 2009, 199(10):1506-1513. 10.1086/598686, 19331578.
41. Burton JP, Cadieux PA, Reid G. Improved understanding of the bacterial vaginal microbiota of women before and after probiotic instillation. Appl Environ Microbiol 2003, 69(1):97-101. 10.1128/AEM.69.1.97-101.2003, 152440, 12513982.
42. Gardiner GE, Heinemann C, Bruce AW, Beuerman D, Reid G. Persistence of Lactobacillus fermentum RC-14 and Lactobacillus rhamnosus GR-1 but not L. rhamnosus GG in the human vagina as demonstrated by randomly amplified polymorphic DNA. Clin Diagn Lab Immunol 2002, 9(1):92-96. 119863, 11777835.
43. Verstraelen H, Verhelst R, Vaneechoutte M, Temmerman M. The epidemiology of bacterial vaginosis in relation to sexual behaviour. BMC Infect Dis 10:81.
44. Potter J. Should sexual partners of women with bacterial vaginosis receive treatment?. Br J Gen Pract 1999, 49(448):913-918. 1313567, 10818662.
45. Vejtorp M, Bollerup AC, Vejtorp L, Fanoe E, Nathan E, Reiter A, Andersen ME, Stromsholt B, Schroder SS. Bacterial vaginosis: a double-blind randomized trial of the effect of treatment of the sexual partner. Br J Obstet Gynaecol 1988, 95(9):920-926. 10.1111/j.1471-0528.1988.tb06581.x, 3056506.
46. Moi H, Erkkola R, Jerve F, Nelleman G, Bymose B, Alaksen K, Tornqvist E. Should male consorts of women with bacterial vaginosis be treated?. Genitourin Med 1989, 65(4):263-268. 1194366, 2680896.
47. Swedberg J, Steiner JF, Deiss F, Steiner S, Driggers DA. Comparison of single-dose vs one-week course of metronidazole for symptomatic bacterial vaginosis. Jama 1985, 254(8):1046-1049. 10.1001/jama.254.8.1046, 3894707.
48. Heikkinen J, Vuopala S. Anaerobic vaginosis: treatment with tinidazole vaginal tablets. Gynecol Obstet Invest 1989, 28(2):98-100. 10.1159/000293524, 2792920.
49. Mengel MB, Berg AO, Weaver CH, Herman DJ, Herman SJ, Hughes VL, Koepsell TD. The effectiveness of single-dose metronidazole therapy for patients and their partners with bacterial vaginosis. J Fam Pract 1989, 28(2):163-171.
50. Sobel JD, Schmitt C, Meriwether C. Long-term follow-up of patients with bacterial vaginosis treated with oral metronidazole and topical clindamycin. J Infect Dis 1993, 167(3):783-784. 10.1093/infdis/167.3.783, 8440952.
51. Schwebke JR, Desmond R. A randomized trial of metronidazole in asymptomatic bacterial vaginosis to prevent the acquisition of sexually transmitted diseases. Am J Obstet Gynecol 2007, 196(6):517 e511-516.
52. Reichman O, Akins R, Sobel JD. Boric Acid Addition to Suppressive Antimicrobial Therapy for Recurrent Bacterial Vaginosis. Sex Transm Dis 2009,